Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” ...

OT gathered insight from organisers of 100% Optical as delegates make plans in the final weeks running up to the show ...

EPWK HOLDINGS LTD. (the "Company") (NasdaqGM: EPWK), a company that connects businesses with great talents through innovative ...

The Shiloh Museum of Ozark History is kicking off 2025 with an exciting lineup of events and activities, offering something for everyone both at the museum and throughout the Ozarks. From programs on ...

With its latest announcement, Leica is furthering its focus on mobile photography, adding a new accessory to its lineup. The ...

GAAP diluted EPS of $4.78, +14% y/y ; 2024 adj. diluted EPS of $6.07, +8% y/y ; Record 2024 operating income of $4.3 billion, +1 ...

FY'25 guidance revised: revenue expected to decrease by high single digit year-on-year at constant exchange rates and perimeter (compared to flat previously), and EBITDA1 margin2 expected between 32% ...

Patient enrollment is expected to begin in the first half of 2025, subject to final protocol review by regulatory authorities ...

About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...

The project will feature an updated Plank House restaurant, two indoor digital golf suites and a Heritage-branded tasting room. Spanning two levels and with panoramic views of Coos Bay, the tasting ...

Microchip Technology Incorporated ( NASDAQ: MCHP) Q3 2025 Earnings Conference Call February 6, 2025 5:00 PM ET Steve Sanghi - Chief Executive Officer Eric Bjornholt - Chief Financial Officer Rich ...